Janice Johnson

Title: Janice Johnson: Innovator in Cardiac Treatment

Introduction

Janice Johnson is a prominent inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of biomedical engineering, particularly in the area of cardiac treatment. Her innovative work has led to the development of a unique peptide that has potential therapeutic applications.

Latest Patents

Janice Johnson holds a patent for a "Mechanically activated channel blocker." This invention discloses a peptide of SEQ ID NO:2 and its variants that block stretch-activated ion channels. The peptide, designated as GsMTx-4, is derived from the venom of a spider. The patent also outlines methods for purifying the peptide GsMTx-4 from spider venom and inhibiting stretch-activated ion channels in cells. The cDNA sequence encoding GsMTx-4 is also included in the patent. This peptide and its variants can be utilized for the treatment of cardiac arrhythmias. She has 1 patent to her name.

Career Highlights

Janice Johnson is affiliated with the State University of New York, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cardiac health and treatment options.

Collaborations

Janice has collaborated with notable colleagues, including Frederick Sachs and Thomas Suchyna, who have contributed to her research endeavors.

Conclusion

Janice Johnson's innovative work in developing a peptide for cardiac treatment showcases her dedication to advancing medical science. Her contributions have the potential to significantly improve patient outcomes in the field of cardiology.